MARK SNAVELY: Open Payments
NPI 1942678958 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,765 in 130 payments from 17 companies in 2025. Trend: 2023 $2,541 · 2024 $2,990 · 2025 $2,765
Food & beverage: $2,584Education: $181
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $526 |
| Janssen Biotech, Inc. | 34 | $433 |
| Regeneron Healthcare Solutions, Inc. | 9 | $334 |
| Novartis Pharmaceuticals Corporation | 19 | $275 |
| GENZYME CORPORATION | 4 | $220 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $211 |
| E.R. Squibb & Sons, L.L.C. | 3 | $143 |
| Arcutis Biotherapeutics, Inc. | 1 | $121 |
| Organon LLC | 6 | $119 |
| PFIZER INC. | 5 | $101 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Sotyktu, COSENTYX, Zoryve, ILUMYA, VTAMA.
Industry payments across FL — which companies pay providers there.
